Single‐ and Multiple‐Dose Bioequivalence of Erythromycin Pharmaceutical Alternatives
- 12 November 1980
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 20 (11) , 625-638
- https://doi.org/10.1002/j.1552-4604.1980.tb01679.x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Single-dose fasting bioequivalence assessment of erythromycin stearate tablets in manJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Plasma Levels following Single and Repeated Doses of Erythromycin Estolate and Erythromycin StearateJournal of Pharmaceutical Sciences, 1979
- Bioavailability of Erythromycin Stearate: Influence of Food and Fluid VolumeJournal of Pharmaceutical Sciences, 1978
- Comparison of Erythromycin Ethyl Succinate, Stearate and Estolate Treatments of Group A Streptococcal Infections of the Upper Respiratory TractClinical Pediatrics, 1975
- ESTOLATE AND STEARATE FORMS OF ERYTHROMYCIN IN THE TREATMENT OF ACUTE BETA HÆMOLYTIC STREPTOCOCCAL PHARYNGITISThe Medical Journal of Australia, 1973
- A COMPARISON OF ABSORPTION AFTER ORAL ADMINISTRATION OF ERYTHROMYCIN ESTOLATE AND ERYTHROMYCIN STEARATEThe Medical Journal of Australia, 1971
- Hepatotoxicity of ErythromycinThe Journal of Infectious Diseases, 1969
- COMPARISON OF THE BLOOD LEVELS OBTAINED AFTER SINGLE AND MULTIPLE DOSES OF ERYTHROMYCIN ESTOLATE AND ERYTHROMYCIN STEARATEThe Lancet Healthy Longevity, 1964
- Propionyl Erythromycin Ester Lauryl Sulfate and JaundicePublished by American Medical Association (AMA) ,1961